BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 32248287)

  • 21. Statin-associated incident diabetes: a literature review.
    Park ZH; Juska A; Dyakov D; Patel RV
    Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statin intolerance.
    Laufs U; Scharnagl H; März W
    Curr Opin Lipidol; 2015 Dec; 26(6):492-501. PubMed ID: 26780003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statins Affect Skeletal Muscle Performance: Evidence for Disturbances in Energy Metabolism.
    Allard NAE; Schirris TJJ; Verheggen RJ; Russel FGM; Rodenburg RJ; Smeitink JAM; Thompson PD; Hopman MTE; Timmers S
    J Clin Endocrinol Metab; 2018 Jan; 103(1):75-84. PubMed ID: 29040646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of mitochondria in statin-induced myopathy.
    Apostolopoulou M; Corsini A; Roden M
    Eur J Clin Invest; 2015 Jul; 45(7):745-54. PubMed ID: 25991405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A call for the better utilization of physical activity and exercise training in the defense against cardiovascular disease.
    Murlasits Z
    Phys Sportsmed; 2015 Nov; 43(4):329-32. PubMed ID: 26478474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Impact of Exercise on Statin-Associated Skeletal Muscle Myopathy.
    Chung HR; Vakil M; Munroe M; Parikh A; Meador BM; Wu PT; Jeong JH; Woods JA; Wilund KR; Boppart MD
    PLoS One; 2016; 11(12):e0168065. PubMed ID: 27936249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statin Therapy as Primary Prevention in Exercising Adults: Best Evidence for Avoiding Myalgia.
    Bosomworth NJ
    J Am Board Fam Med; 2016 Nov; 29(6):727-740. PubMed ID: 28076256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coenzyme Q10 and statin-related myopathy.
    Drug Ther Bull; 2015 May; 53(5):54-6. PubMed ID: 25977402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coenzyme Q10 reverses mitochondrial dysfunction in atorvastatin-treated mice and increases exercise endurance.
    Muraki A; Miyashita K; Mitsuishi M; Tamaki M; Tanaka K; Itoh H
    J Appl Physiol (1985); 2012 Aug; 113(3):479-86. PubMed ID: 22653988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statin-associated muscle symptoms-Managing the highly intolerant.
    Backes JM; Ruisinger JF; Gibson CA; Moriarty PM
    J Clin Lipidol; 2017; 11(1):24-33. PubMed ID: 28391891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Muscle and statins: from toxicity to the nocebo effect.
    Pedro-Botet J; Climent E; Benaiges D
    Expert Opin Drug Saf; 2019 Jul; 18(7):573-579. PubMed ID: 31070941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HMG-CoA reductase inhibitors and coenzyme Q10.
    Nawarskas JJ
    Cardiol Rev; 2005; 13(2):76-9. PubMed ID: 15705257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low vitamin D does not predict statin associated muscle symptoms but is associated with transient increases in muscle damage and pain.
    Taylor BA; Lorson L; White CM; Thompson PD
    Atherosclerosis; 2017 Jan; 256():100-104. PubMed ID: 27993387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnostics and treatment of statin-associated muscle symptoms].
    Kassner U; Grunwald S; Spira D; Buchmann N; Bobbert T; Gazzerro E; Hollstein T; Spuler S; Steinhagen-Thiessen E
    Internist (Berl); 2021 Aug; 62(8):827-840. PubMed ID: 34143250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statin withdrawal and health-related quality of life in a primary cardiovascular prevention cohort.
    Peyrel P; Mauriège P; Frenette J; Laflamme N; Greffard K; Huth C; Bergeron J; Joanisse DR
    Qual Life Res; 2023 Jul; 32(7):1943-1954. PubMed ID: 36781811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H; Fager G
    Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of HMG-CoA reductase inhibitors on coenzyme Q10: possible biochemical/clinical implications.
    Hargreaves IP; Duncan AJ; Heales SJ; Land JM
    Drug Saf; 2005; 28(8):659-76. PubMed ID: 16048353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association.
    Warden BA; Guyton JR; Kovacs AC; Durham JA; Jones LK; Dixon DL; Jacobson TA; Duell PB
    J Clin Lipidol; 2023; 17(1):19-39. PubMed ID: 36115813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-term cessation of statin therapy does not alter aerobic exercise performance in physically active middle-aged adults.
    Ballard KD; Mazur SM; Taylor BA; Thompson PD
    Phys Sportsmed; 2016; 44(1):63-7. PubMed ID: 26738560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of statins on cellular respiration and de-differentiation of myofibroblasts in human failing hearts.
    Emelyanova L; Sra A; Schmuck EG; Raval AN; Downey FX; Jahangir A; Rizvi F; Ross GR
    ESC Heart Fail; 2019 Oct; 6(5):1027-1040. PubMed ID: 31520523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.